Menu
ncarol.com
  • Home
  • Books
  • Book Release
  • Technology
  • Education
  • Health
  • Music
  • Business
  • Financial
ncarol.com

CCHR Warns of ADHD Drug Risks as WHO Denies Essential Status for Stimulant
ncarol.com/10249596

Trending...
  • T. Jones Group's Cameron Jones Serves as Judge for the 2026 CHBA National Awards for Housing Excellence
  • $29.8 Million Record Setting Q1 with Boosted Annual Guidance to $160 Million for Expanding Pre-Owned Boat Dealer: Off The Hook YS, Inc. N Y S E: OTH
  • Kaltra Expands Microchannel Water Coil Line for U.S. HVAC Market With New Corrosion-Resistant Tube Technology
3.3 million children are given psychiatric drugs
Mental health industry watchdog discloses that 3.3 million U.S. children are given psychiatric drugs despite WHO disapproving of these for children younger than 12

LOS ANGELES - ncarol.com -- In a recent Lancet Psychiatry article, experts have supported the World Health Organization's decision to withhold essential medicine status from methylphenidate, a drug used for Attention Deficit Hyperactivity Disorder (ADHD). The latest WHO Model List of Essential Medicines (EML) has gone even further by removing the antipsychotics chlorpromazine and haloperidol, and the antidepressant fluoxetine for children. Indeed, "The current EML contains no medications of any kind to treat mental disorders in children younger than 12 years, which aligns with current evidence," Lancet reported.[1] Despite this, the Citizens Commission on Human Rights International says that over 3 million U.S. children aged 12 and younger are prescribed psychiatric drugs, as per statistics from the IQVia Total Patient Tracker database.[2]

IQVia statistics reveal that of the 3.3 million, 1,809,101 are prescribed stimulants for ADHD; 336,125 are prescribed antipsychotics, and 581,979 are prescribed antidepressants—the latter, however, are not indicated in anyone younger than 24 because of the risk of suicide. CCHR said the psychotropic drugging of America's children is shameful and putting them at risk.

Ole Jakob Storebø from the Center for Evidence-Based Psychiatry, Psychiatric Research Unit, Denmark, and colleagues wrote, "WHO indicates that precautions are warranted regarding any pharmacological treatment of mental disorders for children younger than 12 years. From an evidence-based perspective, we believe the precautions to be an ethical and sound stance."

Before their passing, the doctors responsible for putting ADHD on the map were aghast at what they helped create. Child psychiatrist Leon Eisenberg, the "scientific father of ADHD", along with child psychologist Keith Conners, Ph.D., conducted clinical trials on methylphenidate in the 1960s. In 2009, he remorsefully called ADHD a "prime example of a fictitious disease."[3] In 2013, Conners said he was appalled at how many children were saddled with the diagnosis, calling it "a national disaster of dangerous proportion."[4]

In 2015, CCHR notified the UN Committee on the Rights of the Child (UNCRC) of the aggressive worldwide diagnosing of ADHD and stimulants prescribed to children, resulting in UNCRC hearings being held. The agency found that "educational resources and funding systems for practitioners are geared toward a 'quick fix'" and recommended the establishment of a system for "monitoring of the excessive use of psychostimulants to children." It called for governments to "take the necessary measures to prevent any pressure on children and parents to accept treatment with psychostimulant drugs."[5]

More on ncarol.com
  • Could You Make a 2026 World Cup Squad? A New Free Tool Will Tell You Where You'd Sit on Any National Team's Bench in 90 Seconds
  • Sugar Land's Social Scene Gets a Boost: Pep's Backyard Set to Open Near Constellation Field
  • Joseph Nybyk (AKA Joseph Neibich) Guests On Octopus TV
  • New from Regal House Publishing, Minerva, a girl raised in a politically divided country
  • Mutant-Fueled Bio-Cyberpunk Shooter HoverGrease 2 Launches May 22

In 2018, and again in 2020, the WHO Expert Committee on the selection and use of essential medicines declined to grant the stimulant drug methylphenidate the status of an essential medicine.[6]

The U.S. Drug Enforcement Administration classifies methylphenidate as a high-abuse Schedule II drug, in the same category as morphine, opium and cocaine. A study in the Journal of Neuroscience said it is more potent than cocaine.[7]

Other stimulant side effects include nervousness, insomnia, blood pressure and pulse changes, weight loss, heart attacks, strokes and sudden death, and new or worsening aggression and hostility.[8] Methylphenidate's manufacturer warns it is a drug of dependency.[9] Last year, the Food and Drug Administration acknowledged ADHD drugs can cause addiction, even when used as prescribed, and required this information be added to its black box warning on all stimulant drugs.[10]

Students also abuse these drugs. Researchers at the University of California, San Diego School of Medicine found brain scans of college students who abused stimulants showed impaired neuronal activity. "If you show me 100 college students and tell me which ones have taken stimulants a dozen times, I can tell you those students' brains are different," Dr. Martin Paulus, professor of psychiatry, said.[11]

In a groundbreaking September 2005 study, the Evidence-based Practice Center of Oregon Health & Science University analyzed 2,287 studies, encompassing virtually all research on ADHD drugs. Surprisingly, none of the trials demonstrated the effectiveness of these drugs, and there was insufficient evidence supporting their positive impact on "academic performance, risky behaviors, social achievements, etc."[12]

The anomaly is the American Psychiatric Association admits, "There are no laboratory tests, neurological assessments, or attentional assessments that have been established as diagnostic in the clinical assessment" of ADHD.[13] The diagnosis is largely based on subjective behavioral symptoms, including not sitting still, losing pencils and not finishing chores.

Kelly O'Meara, former Congressional staff and author of Psyched Out: How Psychiatry Sells Mental Illness and Pushes Pills That Kill, summed it up: "In essence, what is happening is that millions of American children are being put on mind-altering drugs—the equivalent of cocaine—every day and often for years on end, to treat a mental illness that no one can say with certainty an objective, confirmable abnormality exists. The best and brightest in mental health admit they are speculating—guessing—effectively using America's children as dice in a psychopharmacological crapshoot."[14]

More on ncarol.com
  • Triple-Digit Growth, OTCQX Market Upgrade and a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation: Stock Symbol: CDIX
  • XRPPower Continues Strengthening Its Global AI-Powered Blockchain Ecosystem
  • Lick Introduces Pineapple Flavored Massage Oil — A Tropical Date Night Favorite Available on Amazon
  • FutureLot Powers ADU Wizard for Massachusetts Clean Energy Center's Statewide ADU Resource Center
  • ICT Innovations Releases ICTPBX Community Edition as Open Source Under Mozilla Public License 2.0

About CCHR: CCHR was founded in 1969 by the Church of Scientology and the late Dr. Thomas Szasz, Professor of Psychiatry. It has helped achieve over 190 laws to protect the rights of patients within the mental health system.

[1] www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(23)00395-4/fulltext
[2] www.cchrint.org/psychiatric-drugs/people-taking-psychiatric-drugs/
[3] www.cchrint.org/2022/02/14/new-diagnostic-manual-with-adhd-listed-could-turn-childhood-into-a-mental-disorder/
[4] www.cchrint.org/2017/08/23/teen-overdose-deaths-from-adhd-anti-anxiety-drugs-on-the-rise/, citing: www.scientificamerican.com/article/big-pharma-s-manufactured-epidemic-the-misdiagnosis-of-adhd; rss.onlinelibrary.wiley.com/doi/full/10.1111/j.1740-9713.2016.00979.x
[5] www.cchr.org/newsletter/2015-summer-child-drugging-reports-worldwide-abuse.html; www2.ohchr.org/english/bodies/crc/docs/co/crc-c-can-co-3-4_en.pdf; docstore.ohchr.org/SelfServices/FilesHandler.ashx?enc=6QkG1d%2FPPRiCAqhKb7yhskw6ZHlSjLETdRql6Pfo3d19G0fwi7ZPZdEOVKAQgeqWKogX2iXEvcG5O%2BzGKtEo1nvnVtG%2FXYEnmWa47plmDxnXlhPMHh5Fz%2FKc%2FL6gvzos
[6] www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(23)00395-4/fulltext
[7] www.deadiversion.usdoj.gov/drug_chem_info/methylphenidate.pdf; Brian Vastag, "Pay Attention: Ritalin Acts Much Like Cocaine," JAMA, 22/29 Aug. 2001, Vol. 286, No. 5, p. 906
[8] Physicians' Desk Reference, (Medical Economics Company, New Jersey, 1998), pp. 1896-1897; DSM-III, p. 150; PDR.Net, www.pdr.net/drug-summary/?drugLabelId=1003; Ricardo Alonso-Zaldivar, "Warning Urged for ADHD Drugs," Los Angeles Times, Feb. 10, 2005; www.cchrint.org/2023/05/16/fda-finally-adds-addiction-to-black-box-warning-on-adhd-drugs/
[9] www.novartis.com/us-en/sites/novartis_us/files/ritalin_la.pdf
[10] www.cchrint.org/2023/05/16/fda-finally-adds-addiction-to-black-box-warning-on-adhd-drugs/; "FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions," FDA 11 May 2023; www.cchrint.org/2023/05/16/fda-finally-adds-addiction-to-black-box-warning-on-adhd-drugs/
[11] www.counselheal.com/articles/9144/20140326/even-occasional-stimulant-use-dulls-brain.htm
[12] www.counselheal.com/articles/9144/20140326/even-occasional-stimulant-use-dulls-brain.htm
[13] Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, (American Psychiatric Association, Washington D.C. 2000), pp. 88-89
[14] Kelly Patricia O'Meara, Psyched Out: How Psychiatry Sells Mental Illness and Pushes Pills that Kill, (AuthorHouse, 2006), p. 75

Contact
Amber Rauscher
***@cchr.org


Source: Citizens Commission on Human Rights
Filed Under: Education

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Avery Headley Leads Major Stabilization and Modernization Initiative Across Bronx Affordable Housing Portfolio
  • America's Boating Channel® Releases New Video Explaining Give-Way and Stand-On Vessel Navigation Rules
  • NewReputation's AI Sentiment Analysis Tool Reaches 2,500 Users as Businesses Demand Clearer Brand Intelligence
  • Sunday Best Winner Tasha Page-Lockhart Headlines A'Leurer's 1-Year Anniversary Celebration in Greensboro
  • CAPO Supply Announces Opening of Second Location in New Castle, Pennsylvania
  • $224 Billion Growing Market in Life Settlements Presents Major Opportunity for New Policy Acquisition Business Plan: DLT Resolution Stock Symbol: DLTI
  • New from Regal House Publishing, Margery and Me, based on the true story of psychic Margery Crandon
  • Fyt-02 Launches on Kickstarter The Smart Sensor That Turns Any Chair Into a Posture & Movement Track
  • YieldOMega Launches $DOUB Airdrop Campaign Ahead of TimeCurve Launch
  • Kaltra Expands Microchannel Water Coil Line for U.S. HVAC Market With New Corrosion-Resistant Tube Technology
  • Collectibles EvoRelic Celebrates Stellar 4.8-Star Customer Rating
  • Phoenix Hip-hop Artist Rhymi Hits 23k Monthly Listeners 12 Days After Album Release
  • Pediatrician Launches "Confessions of a Detective Doctor" Children's Book Series
  • Integrated Maintenance Platforms Are Transforming Aircraft Operations
  • T. Jones Group's Cameron Jones Serves as Judge for the 2026 CHBA National Awards for Housing Excellence
  • Derek Advanced Tracking Systems Revolutionizes Asset Monitoring with Advanced Technology
  • The AI Direction Deficit: TripleTen Study Finds Staff Get Told to Use AI — But Not Trained to Use It
  • $29.8 Million Record Setting Q1 with Boosted Annual Guidance to $160 Million for Expanding Pre-Owned Boat Dealer: Off The Hook YS, Inc. N Y S E: OTH
  • All About Technology Celebrates 25 Years of Bridging Detroit's Digital Divide
  • iatroX surpasses 500,000 clinical queries and expands specialist exam coverage
_catLbl0 _catLbl1

Popular on ncarol.com

  • Advanced TeleSensors Appoints AgeTech Innovator Tiffany Wey, MBA as Vice President of Sales & Marketing - 121
  • $112 Million Contract Backlog for Cycurion (N A S D A Q: CYCU) Enters Hyper-Growth Phase With, Strategic Acquisitions, & Exploding AI Cybersecurity - 116
  • Virginia Moving Company Nearly Doubles Customer Calls in Two Weeks After Switching to CARL — the Bold New Alternative to WordPress - 108
  • Altruvest and Financial Executives International Canada Announce Strategic Partnership to Strengthen Nonprofit Boards Across Canada - 105
  • Most Americans Choose Their Water Brand Because of Its Natural Source — Yet Fewer Than 3 in 10 Understand What Spring Water Actually Is - 102
  • RAS AP Consulting Advances to RFP Stage in Heidelberg Materials' SAP Vendor & Customer Master Data Modernization Initiative
  • CCHR Report Links 145 Violent Incidents to Psychiatric Drug Exposure, Urges National Oversight and Action
  • 5,521 College Athletes Launch Own Merch Stores in Just 30 Days on AthleteMerch.com, Reaching 7,975 Live Storefronts Nationwide
  • Appliance EMT Presents Multi-Thousand Dollar Donation to Kids Motel Ministry to Support Local Families
  • T. Jones Group's Cameron Jones Serves as Judge for the 2026 CHBA National Awards for Housing Excellence

Similar on ncarol.com

  • ASCLD Honors Jeremy Triplett with 2026 Briggs J. White Award
  • Federal indictments bring new scrutiny to SPLC practices and highlight the real‑world impact of its designations on nonprofit groups, including NCFM
  • Triple-Digit Growth, OTCQX Market Upgrade and a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation: Stock Symbol: CDIX
  • Raymond Lavine, Extended Care Benefits Advisor and Author, to Appear on National Television Series Moving America Forward
  • NaturismRE Launches Structured Nudism & Naturism Encyclopedia, Aiming to Reframe Public Understanding
  • CCHR Highlights Concerns Over Coercive and Failed $140 Billion Mental Health Practices at Psychiatric Convention
  • Avery Headley Leads Major Stabilization and Modernization Initiative Across Bronx Affordable Housing Portfolio
  • Fyt-02 Launches on Kickstarter The Smart Sensor That Turns Any Chair Into a Posture & Movement Track
  • Pediatrician Launches "Confessions of a Detective Doctor" Children's Book Series
  • The AI Direction Deficit: TripleTen Study Finds Staff Get Told to Use AI — But Not Trained to Use It
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute